Battle to control malaria in Cambodia 'not over'

NewsGuard 100/100 Score

"Two years after some $22 million in donor funds were pumped into malaria control along the Cambodia-Thailand border to fight off suspected resistance to treatment, health workers say the battle is not over," IRIN reports, adding, "The government reported 103,000 malaria infections and 151 deaths nationwide in 2010. A year later, 85,000 reported infections led to 93 deaths -- a 38-percent decline in mortality." "'If you take your foot off the … [accelerator] we can lose everything we have done in the past two to three years,' Steven Bjorge, anti-malaria team leader in Cambodia for the [WHO], told IRIN in February 2012," the news service writes.

"The government has announced a goal of zero malaria cases by 2025, but is struggling to hang on to donor funds," according to IRIN. "The Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria pledged almost $80 million in two current grants to fight malaria in Cambodia, but government agencies were unable to collect some $20 million -- 35 percent of one grant -- due to 'performance below the expectations,' said Andrew Hurst, a Global Fund spokesman," the news service notes (6/7).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show